These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27894250)

  • 1. Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients.
    Chalghoum A; Noichri Y; Dandana A; Baudin B; Miled A; Ferchichi S
    BMC Cardiovasc Disord; 2016 Nov; 16(1):244. PubMed ID: 27894250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic interactions between hyperhomocysteinemia and endothelin-1 among Tunisian patients with acute coronary diseases.
    Chalghoum A; Noichri Y; Karkouch I; Dandana A; Baudin B; Jeridi G; Ferchichi S; Miled A
    Biol Res; 2015 Jun; 48(1):32. PubMed ID: 26103962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease.
    Al-Fakhri N; Linhart RE; Philipp M; Heidt M; Hehrlein FW; Gardemann A; Katz N
    J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pro-oxidant effect of angiotensin-1 converting enzyme in Tunisian patients with coronary heart disease.
    Chalghoum A; Noichri Y; Mohamed MH; Dandana A; Baudin B; Ferchichi S; Miled A
    Acta Biomed; 2012 Dec; 83(3):202-7. PubMed ID: 23762996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic interactions between the hyperhomocysteinemia and angiotensin-1 converting enzyme activity in Tunisian patients with coronary heart disease].
    Chalghoum A; Noichri Y; Chkioua L; Gammoudi I; Dandana A; Khelil S; Jeridi G; Baudin B; Ferchichi S; Miled A
    Ann Biol Clin (Paris); 2012 Oct; 70(5):599-604. PubMed ID: 23047907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population.
    Mehri S; Baudin B; Mahjoub S; Zaroui A; Bénéteau-Burnat B; Mechmeche R; Hammami M; Ben Arab S
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):85-91. PubMed ID: 20059382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the A(8002)G intronic polymorphism of pre-pro-endothelin-1 gene and the endothelin-1 concentration among Tunisian coronary patients.
    Chalghoum A; Noichri Y; Dandana A; Azaiez S; Baudin B; Jeridi G; Miled A; Ferchichi S
    BMC Cardiovasc Disord; 2015 Nov; 15():152. PubMed ID: 26573609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease.
    Proudler AJ; Crook D; Godsland IF; Collins P; Rosano GM; Stevenson JC
    J Clin Endocrinol Metab; 1995 Feb; 80(2):696-9. PubMed ID: 7852538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of some vasoactive mediators in patients with erectile dysfunction: their relationship with angiotensin-converting enzyme and growth hormone.
    Hamed EA; Meki AR; Gaafar AA; Hamed SA
    Int J Impot Res; 2003 Dec; 15(6):418-25. PubMed ID: 14671660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin converting enzyme inhibitors on periprocedural myocardial infarction in patients with metabolic syndrome.
    Ozcan OU; Ustun EE; Gulec S; Gerede DM; Goksuluk H; Vurgun VK; Kaya CT; Erol C
    Cardiol J; 2015; 22(3):323-9. PubMed ID: 25563711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of hyper- and dyslipidemias on activity of angiotensin-converting enzyme (biochemical disturbances in metabolic syndrome)].
    Al'tshuler BIu; Roĭtman AP; Dolgov VV; Sokolov AV
    Ter Arkh; 2005; 77(1):51-6. PubMed ID: 15759455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional risk factors and angiotensin-converting enzyme insertion/deletion gene polymorphism in coronary artery disease.
    Sahin S; Ceyhan K; Benli I; Ozyurt H; Naseri E; Tumuklu MM; Aydogan L; Elalmis AO; Ozugurlu AF; Onalan O
    Genet Mol Res; 2015 Mar; 14(1):2063-8. PubMed ID: 25867352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of endothelin-1 concentration and angiotensin-converting enzyme activity with the staging of liver fibrosis.
    Kardum D; Fabijanić D; Lukić A; Romić Z; Petrovecki M; Bogdanović Z; Jurić K; Urek-Crncević M; Banić M
    Coll Antropol; 2012 Jun; 36(2):413-8. PubMed ID: 22856224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I-converting enzyme gene polymorphism enhances the effect of hypercholesterolemia on the risk of coronary heart disease in a general Japanese population: the hisayama study.
    Kondo H; Ninomiya T; Hata J; Hirakawa Y; Yonemoto K; Arima H; Nagata M; Tsuruya K; Kitazono T; Kiyohara Y
    J Atheroscler Thromb; 2015; 22(4):390-403. PubMed ID: 25342476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in angiotensin convertase enzyme (ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery.
    Daragó A; Fagyas M; Siket IM; Facskó A; Megyesi Z; Kalász J; Galajda Z; Szerafin T; Hársfalvi J; Edes I; Papp Z; Tóth A; Szentmiklósi J
    Cardiovasc Ther; 2012 Jun; 30(3):136-44. PubMed ID: 21106034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M; Sertić J; Duraković Z
    Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunostaining of angiotensin-converting enzyme in human coronary atherosclerotic plaques.
    Ribichini F; Pugno F; Ferrero V; Bussolati G; Feola M; Russo P; Di Mario C; Colombo A; Vassanelli C
    J Am Coll Cardiol; 2006 Mar; 47(6):1143-9. PubMed ID: 16545643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on relationship between the polymorphism of angiotensin converting enzyme gene and blood stasis syndrome in patients with coronary heart disease].
    Mao YL; Yuan ZK; Huang XP; Lu F; Tan G; Hu Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Sep; 24(9):776-80. PubMed ID: 15495818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.